Skip to content
OpenCapital
Get started

KMTS KMTS Payments Of Debt Issuance Costs

Payments Of Debt Issuance Costs at other companies

Haemonetics logo
HaemoneticsHAE
——

Other financials

Income statement

See full
Revenue$24.6M+62.7%
Gross profit$12.9M+97.1%
Operating income-$34.8M-68.8%
Net income-$34.2M-58.8%
EPS (diluted)-$0.61+51.2%

Balance sheet

See full
Cash & equivalents$291.3M+436%
Total debt$43.8M—
Total assets$379.3M—

Cash flow

See full
Operating cash flow-$18.4M-2.1%
CapEx$9.8M+141%
Free cash flow-$28.2M-27.7%

Valuation

See full
Market cap$1.32B+70.8%
Enterprise value$1.07B—
P/S15.7×—

Profitability

See full
Gross margin48.8%+15.1pp
Operating margin-171.5%+12.9pp
Net margin-173%+0.8pp
FCF margin-142.9%-25.3pp

Returns & leverage

See full
Current ratio7.3×—

Where this comes from

Reported directly by KMTS in its filing.

Tagged under the XBRL concept us-gaap:PaymentsOfDebtIssuanceCosts.

The official record: KMTS’s 10-K, filed July 17, 2025, on SEC EDGAR. View the filing →

Ask your AI about KMTS's payments of debt issuance costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is KMTS's payments of debt issuance costs?
KMTS (KMTS) reported payments of debt issuance costs of $588.25K in Q1 2024.